stock
MLTX · MoonLake Immunotherapeutics
What MoonLake Immunotherapeutics reports to the SEC, read from its filings.
Open in the appPrice
The live MLTX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on MLTX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 85,106,685 as of 2026-08-01 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -61.6%
- ROA
- -45.9%
Health
- Current ratio
- 12.6x
- Debt/equity
- 0.2x
Deep value
- NCAV
- $424.29M
- NCAV per share
- $4.99
- Price/NCAV
- Locked
- NNWC
- $332.15M
- NNWC per share
- $3.90
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$61.66M | -$61.80M | 10-Q filed 2026-08-10 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$70.02M | -$69.71M | 10-Q filed 2026-05-11 |
| 2025-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$65.22M | -$62.42M | DEF 14A filed 2026-04-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$71.43M | -$69.73M | 10-Q filed 2025-11-05 |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$60.70M | -$55.22M | 10-Q filed 2026-08-10 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$47.48M | -$39.94M | 10-Q filed 2026-05-11 |
| 2024-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$49.58M | -$45.61M | DEF 14A filed 2026-04-21 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$43.11M | -$35.39M | 10-Q filed 2025-11-05 |
- Assets
- $573.95M
- Equity
- $428.19M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$244.83M | -$227.32M | -$196.04M |
| 2024-12-31 | — | -$143.09M | -$118.94M | -$117.11M |
| 2023-12-31 | — | -$54.12M | -$36.01M | -$43.06M |
| 2022-12-31 | — | -$65.06M | -$49.97M | -$55.91M |
| 2021-12-31 | — | -$4.57M | -$4.54M | — |
Company filings
since Mon Aug 10 · 3 offering filings in 12 months
events
Other event
Other eventSep 308-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureAug 108-KOther event
Other eventJul 148-KMaterial agreement
Material agreementJun 258-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventJun 228-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 98-K
5% owners ()
Cormorant Asset Management, LP
Stake update
T. Rowe Price Investment Management, Inc.
Passive stake
Deep Track Capital, LP
Stake update
BIOTECHNOLOGY VALUE FUND L P
Stake update
Cormorant Asset Management, LP
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Couldn’t load insider trades
This read is unavailable. Try it again without changing anything on the page.
Politician trades, last 90 days
Couldn’t load politician trades
This read is unavailable. Try it again without changing anything on the page.
News
Stories that named MLTX, and the market events around them.
Sign in to see thisBoard
The MLTX board could not be loaded.
Retry the MLTX boardnakagai
Signals on MLTX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the MLTX board